Paper Details

  1. Home
  2. Paper Details

Comparing gatifloxacin and clarithromycin in pneumonia symptom resolution and process of care.

Author: DeanNathan C, HadlockCarol, SperryPaul, SuchytaMary S, WiklerMatthew

Comparative StudyResearch that compares multiple groups/interventions to determine differences/similarities in outcomes/characteristics.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Multicenter StudyResearch conducted in collaboration with multiple research institutions. It aims to collect a wide range of data and obtain more generalizable results.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.

Overview

This study compared the symptom resolution, side effects, and care processes associated with clarithromycin versus gatifloxacin for treating radiographically confirmed community-acquired pneumonia. Gatifloxacin monotherapy was compared to clarithromycin alone or combined with ceftriaxone in patients with multiple risk factors. Symptom resolution was similar between groups, but gatifloxacin was associated with lower antibiotic costs, fewer taste disturbances, and less injection site soreness.
Paper Details　
Original Abstract of the Article :
In looking for outcome differences beyond rates of cure, we prospectively compared the symptom resolution, side effects, and processes of care between the use of clarithromycin and gatifloxacin for the treatment of radiographically confirmed community-acquired pneumonia. We conducted a multicenter, ...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1426950/

データ提供：米国国立医学図書館（NLM）

Comparing Antibiotics for Pneumonia: Finding the Right Treatment in a Desert of Symptoms

Pneumonia, like a sudden desert sandstorm, can strike with unexpected force. This study compares the effectiveness of gatifloxacin and clarithromycin, two antibiotics commonly used to treat community-acquired pneumonia. The study analyzes the symptom resolution, side effects, and treatment processes associated with each antibiotic, similar to comparing different strategies for navigating a desert landscape. The study found no significant differences in symptom resolution or return to usual activities between the two antibiotics, but gatifloxacin was associated with lower antibiotic costs and fewer side effects.

Navigating the Desert of Pneumonia: A Guide to Treatment

The study provides valuable insights for healthcare providers in choosing the most appropriate antibiotic treatment for community-acquired pneumonia. It's like having a guidebook to navigate the desert of pneumonia, equipped with information to make informed decisions about the best path to take. The study highlights the importance of considering cost and side effects, along with the effectiveness of treatment, in making optimal choices for patient care.

A World of Microbes: Understanding the Desert Landscape

The study reminds us of the complex world of bacteria and the ongoing battle against infections. It's like exploring a vast desert, where each microbe represents a unique species, some beneficial and others harmful. Understanding the characteristics of different microbes and their susceptibility to antibiotics is crucial for effective treatment and prevention of infections. The study encourages continued research in developing new antibiotics and optimizing treatment strategies to combat the ever-evolving desert of microbial threats.

Dr. Camel's Conclusion

This study provides valuable guidance for healthcare professionals in choosing the most appropriate antibiotic treatment for pneumonia. It's a reminder that even in the vast and challenging desert of microbial threats, we have the tools and knowledge to effectively fight against infection and protect our health.

Date :
  1. Date Completed 2006-06-09
  2. Date Revised 2018-12-01
Further Info :

Pubmed ID

16569825

DOI: Digital Object Identifier

PMC1426950

Related Literature

Article Analysis
・Side Effects of cefotaxime injection
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.